Patent ID: 7393638

Claim:
An assay system for detecting SARS (severe acute respiratory syndrome) coronavirus (SARS-CV) DNA from a sample of a suspected patient, the system comprising: (i) a diagnostic kit for detecting biotinylated SARS coronavirus (SARS-CV) DNA, which is amplified in advance by biotinylated primers, in the presence of hybridization buffer, said kit comprising: (a) a probe consisting of the sequence amine-TAGAGGGCTGTCATGCAACT (SEQ ID NO: 3) linked to a magnetic bead; (b) avidin enzyme complex or streptavidin enzyme complex; and (c) substrate for said enzyme; (ii) an apparatus for performing the dissociation of nucleic acid double strands, hybridization, washing, the separation of magnetic beads and thermal control in the same apparatus, comprising: (a) a means for fitting reaction containers; (b) a means for controlling the temperature of the containers; and (c) a means for controlling the magnetic force of the containers, wherein the means for controlling the temperature of the containers are connected to the means for fitting reaction containers, and the means for controlling the magnetic force of the containers are connected to the means for fitting reaction containers; (iii) a magnetic rack to bind the magnetic beads on the wall of the containers; and (iv) a detector for the reaction of the substrate with the enzyme.